A phase II study of cisplatin(C), irinotecan (I) and bevacizumab (B) for untreated extensive stage small cell lung cancer (ES-SCLC)
   Google Scholar   
Citation:
J Clin Oncol vol 25 (18s) abstr 7563
Year:
2007
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
174  
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
             
Networks:
 
Study
CALGB-30306
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: